| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
48,935 |
45,642 |
$3.14M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
9,945 |
9,545 |
$928K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
7,822 |
7,704 |
$716K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
9,128 |
8,694 |
$716K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
6,325 |
6,280 |
$602K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
28,827 |
27,966 |
$515K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
3,998 |
3,974 |
$407K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
8,760 |
8,445 |
$365K |
| 90461 |
|
11,285 |
10,890 |
$168K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
12,806 |
12,482 |
$144K |
| 92587 |
|
4,983 |
4,816 |
$91K |
| 92551 |
|
7,785 |
7,714 |
$73K |
| 90686 |
|
5,671 |
5,471 |
$33K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
1,115 |
1,107 |
$31K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
2,105 |
2,079 |
$27K |
| 90670 |
|
1,974 |
1,896 |
$23K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
2,099 |
2,080 |
$17K |
| 99177 |
|
2,732 |
2,673 |
$15K |
| 90677 |
|
819 |
795 |
$13K |
| 96160 |
|
5,175 |
5,060 |
$10K |
| 90734 |
|
216 |
214 |
$8K |
| 99173 |
|
3,456 |
3,436 |
$8K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
490 |
480 |
$6K |
| 90651 |
|
56 |
56 |
$5K |
| 90716 |
|
318 |
301 |
$4K |
| 99188 |
|
384 |
314 |
$4K |
| 92015 |
Determination of refractive state |
345 |
345 |
$4K |
| 90707 |
|
431 |
408 |
$3K |
| 90620 |
|
52 |
51 |
$3K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
24 |
24 |
$2K |
| 90680 |
|
1,307 |
1,247 |
$2K |
| 90633 |
|
470 |
444 |
$2K |
| 99460 |
|
38 |
38 |
$2K |
| 92558 |
|
347 |
340 |
$2K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
37 |
37 |
$2K |
| 99381 |
|
24 |
24 |
$2K |
| 90656 |
|
585 |
585 |
$2K |
| 99384 |
|
13 |
13 |
$1K |
| 99441 |
|
111 |
107 |
$1K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
13 |
13 |
$1K |
| 96127 |
|
272 |
272 |
$1K |
| 90698 |
|
254 |
244 |
$1K |
| 90687 |
|
71 |
71 |
$997.20 |
| 90648 |
|
1,648 |
1,571 |
$760.98 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
93 |
91 |
$621.16 |
| 36416 |
|
474 |
443 |
$613.09 |
| 92081 |
|
24 |
24 |
$596.28 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
57 |
45 |
$522.32 |
| 0071A |
|
14 |
14 |
$520.00 |
| 99442 |
|
24 |
23 |
$508.74 |
| 90715 |
|
25 |
25 |
$336.86 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
13 |
13 |
$260.60 |
| A7003 |
Administration set, with small volume nonfiltered pneumatic nebulizer, disposable |
231 |
218 |
$260.40 |
| 90696 |
|
46 |
43 |
$222.81 |
| 83655 |
|
100 |
93 |
$174.49 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
62 |
47 |
$168.19 |
| 94760 |
|
6,447 |
6,173 |
$126.43 |
| 90723 |
|
736 |
687 |
$90.05 |
| 99058 |
|
903 |
890 |
$61.95 |
| 90744 |
|
48 |
48 |
$51.71 |
| 90700 |
|
12 |
12 |
$32.88 |
| 91307 |
|
21 |
21 |
$3.00 |
| 99072 |
|
3,204 |
3,051 |
$0.00 |
| 99000 |
|
12 |
12 |
$0.00 |